Jarrow Formulas N-A-C Sustain 600 mg, 60 Bilayer Sustained-Release Tablets Review
#10 of 10 · Unproven Delivery Gimmick✓ Label verified · Supplement Facts read Sep 7, 2026Real retailer photo, cut out. Label unedited.
Skip it. Clever-sounding delivery with no outcome data behind it. The bilayer sustained-release format is a reasonable idea for NAC's short half-life, but there's no clinical evidence it beats standard NAC on any measured outcome.
$13.95~$0.23 per 600 mg tablet
Why It Scores 5.5 — And The Label Line Behind Each Number
Form & Bioavailability
25% of scoreThe bilayer sustained-release format is the only real delivery innovation here, and NAC's short half-life makes the concept plausible — but plausible isn't proven, and no data shows it improves absorption-driven outcomes.
- Form
- Bilayer sustained-release tablet (1/3 immediate + 2/3 sustained)
Third-Party Testing & Purity
25% of scoreNon-GMO, gluten-free, made in USA from a longstanding brand — adequate but unremarkable documentation, with no standout third-party seal or published COA.
- Testing
- Non-GMO, gluten-free, made in USA
- Label caution
- NAC may alter liver-function blood tests without harming the liver
Dose vs Clinical Range
20% of score600 mg/tablet fits the studied range, but trials that established NAC benefits used standard immediate-release dosing, not this timed-release format — so the dose-to-evidence match is indirect.
- Dose
- 600 mg per tablet
Tolerability & Safety
15% of scoreGenerally tolerable, but the label itself warns NAC can transiently alter liver-function blood tests without harming the liver — tell your doctor before bloodwork. Tablet format may suit those who dislike the sulfur-smelling capsules.
Value
15% of score~$0.23/tablet and only 60 tablets, at a premium for a delivery format that isn't proven to add benefit — weak value versus standard NAC.
- Count
- 60 tablets (1-2 month supply)
- Cost per dose
- ~$0.23 per tablet
Label verified. Every figure read from the Supplement Facts photo, Sep 7, 2026.
Marketing Claims Vs. Reality
Sustained release smooths NAC's short plasma half-life
NAC does have a short half-life, and a bilayer timed-release design is a mechanistically plausible way to extend delivery — but plasma-curve smoothing has not been shown to translate into better outcomes.
Sustained release outperforms standard NAC for liver or other outcomes
No clinical trials demonstrate that the sustained-release format produces superior real-world outcomes versus standard immediate-release NAC for any endpoint.
NAC can alter liver-function blood test results
The product label itself notes NAC may affect liver-function blood tests without harming the liver — a documented reason to inform your doctor before bloodwork.
What Our Test Actually Found
A plausible idea is not an outcome
Timed release for a short-half-life molecule sounds smart, and it may well smooth the plasma curve. But no trial shows that smoother curve produces a better liver, respiratory, or mental-health outcome. The premium buys a hypothesis, not a result.
The label's bloodwork warning is worth heeding
Jarrow flags that NAC can alter liver-function blood tests without harming the liver. That's a genuinely useful disclosure — tell your doctor you take NAC before any liver panel to avoid a false alarm.
Full analysis: all pros & cons (7), buy if / skip if
- Only true sustained-release format on the list — a real, if unproven, delivery difference
- Tablet form avoids the sulfur-smelling capsule experience some dislike
- Longstanding, widely reviewed liver-support SKU
- Clear label disclosure about NAC and liver blood tests
- Sustained-release delivery is not clinically proven to beat standard NAC on any outcome
- Premium price for only 60 tablets
- No standout third-party testing seal or published COA
- Only true sustained-release format on the list — a real, if unproven, delivery difference
- Tablet form avoids the sulfur-smelling capsule experience some dislike
- Longstanding, widely reviewed liver-support SKU
- Sustained-release delivery is not clinically proven to beat standard NAC on any outcome
- Premium price for only 60 tablets
- No standout third-party testing seal or published COA
The bilayer sustained-release format is a reasonable idea for NAC's short half-life, but there's no clinical evidence it beats standard NAC on any measured outcome. For a premium price and only 60 tablets, you're buying an unproven delivery gimmick. Standard 600 mg NAC does the studied job for less.
Jarrow's N-A-C Sustain is the only true sustained-release format on this list: a bilayer tablet designed to release one-third of the NAC immediately and two-thirds over hours, aiming to smooth NAC's very short plasma half-life. It's a plausible engineering idea, and it's a longstanding, widely reviewed liver-support SKU. But we rank it last because the sustained-release delivery is not clinically proven to outperform standard NAC for any real-world outcome — you're paying a premium for a delivery hypothesis. Note the label's own warning: NAC can alter liver-function blood tests without harming the liver, so tell your doctor before bloodwork.
Skip the gimmick; buy proven NAC
N-A-C Sustain is a well-made tablet built on a reasonable-sounding delivery idea that simply lacks outcome evidence. There's nothing wrong with it — but you're paying a premium for a sustained-release hypothesis that no trial has validated over standard NAC. For the studied benefits at a better price, a plain 600 mg NAC from NOW or Pure Encapsulations is the smarter buy. Do note the label's liver-test caution regardless of which NAC you choose.
If This Doesn’t Fit — Try These
02NOW NAC 600 mg
For most people this is the correct purchase: a properly dosed, well-tested NAC that costs almost nothing per day.
01Pure Encapsulations NAC 600 mg
If you want the least-adulterated, best-verified NAC and will pay for that peace of mind, this is the one.
Quick Answers
Is sustained-release NAC better than regular NAC?
There's no clinical evidence it is. The bilayer design is a plausible way to extend NAC's short half-life, but no trial shows it improves any real-world outcome over standard immediate-release NAC. You're paying for a delivery hypothesis.
Why does NAC affect liver blood tests?
NAC can transiently alter liver-function test values without actually harming the liver, as Jarrow's own label notes. Tell your doctor you take NAC before any liver panel so a normal medication effect isn't mistaken for a problem.
Sources & Further Reading
2 peer-reviewed sources, each linked to PubMed
- [1] Smilkstein MJ, et al. N Engl J Med. 1988;319(24):1557-1562. PMID 3059186 — Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. The NAC benefits with the strongest evidence were established with standard dosing, not sustained-release formats — the delivery gimmick has no comparable trial support.
- [2] Decramer M, et al. Lancet. 2005;365(9470):1552-1560. PMID 15866309 — Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (BRONCUS). Even standard oral NAC showed mixed outcome results — underscoring that novel delivery formats need their own outcome trials, which sustained-release NAC lacks.
Affiliate disclosure: every Amazon link uses our Associates tag (superachieverclub-20). We earn a small commission at no cost to you; it funds independent reviews. We never accept payment to change a ranking.